Evolving Gene Therapy in Primary Immunodeficiency

Abstract excerpt

Prior to the first successful bone marrow transplant in 1968, patients born with severe combined immunodeficiency (SCID) invariably died. Today, with a widening availability of newborn screening, major improvements in the application of allogeneic procedures, and the emergence of successful hematopoietic stem and progenitor cell (HSC/P) gene therapy, the majority of these children can be identified and cured....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Virus-based gene therapy research
• Share to CAR-T cell therapy research
• Share to RNA Interference and Gene Delivery